Cvs Health (CVS) Notes Payables (2009 - 2025)

Cvs Health's Notes Payables history runs 16 years deep, the most recent figure standing at $1.2 billion for Q3 2025.

• Quarterly Notes Payables rose 55.88% year-over-year to $1.2 billion in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.2 billion (up 55.88% YoY) and the FY2024 annual result came in at $2.1 billion, up 959.5% from the prior year.
• Notes Payables was $1.2 billion for Q3 2025 at Cvs Health, down from $3.0 billion in the prior quarter.
• Across five years, Notes Payables topped out at $3.0 billion in Q2 2025 and bottomed at $200.0 million in Q4 2023.
• A 4-year average of $1.4 billion and a median of $1.2 billion in 2025 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables jumped 959.5% — and 2025, when it sank 53.7%.
• Cvs Health's Notes Payables stood at $252.0 million in 2021, then retreated by 20.63% to $200.0 million in 2023, then soared by 959.5% to $2.1 billion in 2024, then plunged by 41.15% to $1.2 billion in 2025.
• Business Quant data shows CVS's Notes Payables at $1.2 billion in Q3 2025, $3.0 billion in Q2 2025, and $1.3 billion in Q1 2025.